Base Metals Investing Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
Base Metals Investing Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
Base Metals Investing Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting
AMENDED FROM SOURCE - Blue Sky Uranium Increases and Closes 2nd and Final Tranche of the Oversubscribed Non-Brokered Private Placement
